Targeting IGF-1R Enhances Natural Killer Cell Attack Against Myelodysplastic Syndrome Cells
Inhibiting IGF-1R reduces myelodysplastic syndrome cell proliferation, triggers DNA damage, and sensitizes malignant cells to natural killer cell destruction via ...

